2019
DOI: 10.3390/s19051095
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative Measurement and Evaluation of Red Blood Cell Aggregation in Normal Blood Based on a Modified Hanai Equation

Abstract: The aggregation of red blood cells (RBCs) in normal blood (non-coagulation) has been quantitatively measured by blood pulsatile flow based on multiple-frequency electrical impedance spectroscopy. The relaxation frequencies fc under static and flowing conditions of blood pulsatile flow are utilized to evaluate the RBC aggregation quantitatively with the consideration of blood flow factors (RBC orientation, deformation, thickness of electrical double layer (EDL)). Both porcine blood and bovine blood are investig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 28 publications
(31 reference statements)
0
6
0
Order By: Relevance
“…In contrast with bulky viscometers [5,6], a microfluidic-based device can provide numerous advantages including fast response, small volume consumption, and disposability. Currently, such devices are widely employed for quantifying mechanical properties of blood samples (viscosity [7][8][9][10], RBC aggregation [11][12][13][14], RBC deformability [3,15], and hematocrit (Hct) [16][17][18]). A microfluidic device has been also employed to separate RBCs or tumor cells from whole blood sample [19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…In contrast with bulky viscometers [5,6], a microfluidic-based device can provide numerous advantages including fast response, small volume consumption, and disposability. Currently, such devices are widely employed for quantifying mechanical properties of blood samples (viscosity [7][8][9][10], RBC aggregation [11][12][13][14], RBC deformability [3,15], and hematocrit (Hct) [16][17][18]). A microfluidic device has been also employed to separate RBCs or tumor cells from whole blood sample [19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…These alterations contribute to a reduction of mass transport and interrupt the blood flow in capillary vessels. To effectively detect changes in blood samples from a physical point of view, several rheological properties (i.e., viscosity [ 3 , 4 , 5 , 6 ], viscoelasticity [ 7 ], red blood cell (RBC) deformability [ 8 , 9 , 10 , 11 , 12 , 13 ], RBC aggregation [ 14 , 15 , 16 , 17 ], RBC sedimentation rate [ 18 , 19 ], and Hct [ 20 ]) have been measured for screening or diagnosing various diseases, including coronary heart disease, hypertension, diabetes [ 21 ], sickle cell anemia [ 22 , 23 ], and malaria. Plasma protein (i.e., fibrinogen) contributes to increasing RBC aggregation.…”
Section: Introductionmentioning
confidence: 99%
“…Several techniques have been applied to quantify RBC aggregation or the ESR, including those based on electrical impedance [ 5 , 12 , 13 , 14 , 15 ], optical light intensity [ 7 , 16 , 17 ], microscopic image intensity [ 18 , 19 ], interface detection in the tube [ 11 , 20 , 21 ], a holographic laser tweezer [ 6 ], and the shear stress in microfluidic device [ 22 ]. Additionally, an external mechanism (e.g., a pinch valve [ 16 ], vibration motor [ 7 ], driving syringe [ 20 ], or vacuum pump [ 22 ]) can be adopted to periodically run or stop the blood flow in a microfluidic channel.…”
Section: Introductionmentioning
confidence: 99%